Document Detail

Altered immune responses during septicaemia in patients suffering from haematological malignancies.
MedLine Citation:
PMID:  22507327     Owner:  NLM     Status:  In-Data-Review    
Septicaemia is a frequent complication in patients with haematological malignancies. In this study we analysed markers of inflammation/immune activation (C- reactive protein, interleukin-6, neopterin), tryptophan metabolites and mannose binding lectin (MBL) levels consecutively in 36 septic patients with haematological malignancies (HM) and non-haematological diseases [intensive care unit (ICU) patients]. During septicaemia different chronological sequences for inflammation markers CRP, IL-6 and neopterin were seen in HM and ICU patients. Septic ICU-patients presented with significantly increased tryptophan degradation and higher neopterin and CRP levels at baseline, while MBL levels were lower in this group compared to subjects with HM. Concentrations of inflammation markers were linked to each other and associated with enhanced tryptophan degradation. Patients who died during follow-up of 28 days tended to have lower baseline MBL concentrations than survivors. Septic patients with HM showed an impaired pro-inflammatory immune response compared to patients with non-haematological diseases.
K Kurz; K Garimorth; M Joannidis; D Fuchs; A Petzer; G Weiss
Related Documents :
15869667 - Variable electrocardiographic effects of short-term quinidine sulfate administration in...
10888207 - Left ventricular aneurysm without coronary artery disease, incidence and clinical featu...
15586157 - Classification of acute coronary syndromes using the 12-lead electrocardiogram as a guide.
16856707 - Azithromycin-induced qt prolongation in elderly patient.
10561157 - Bedside renal biopsy: ultrasound guidance by the nephrologist.
17283567 - Outcomes of endoscopic sinus surgery for chronic rhinosinusitis associated with sinonas...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of immunopathology and pharmacology     Volume:  25     ISSN:  0394-6320     ISO Abbreviation:  Int J Immunopathol Pharmacol     Publication Date:    2012 Jan-Mar
Date Detail:
Created Date:  2012-04-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8911335     Medline TA:  Int J Immunopathol Pharmacol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  147-56     Citation Subset:  IM    
Department of Internal Medicine I, Clinical Immunology and Infectious Diseases, Medical University of Innsbruck, Innsbruck.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropha...
Next Document:  Prostaglandin E2 to diagnose between reversible and irreversible pulpitis.